Second Ever Cancer Treatment Based on Biomarkers Approved by FDA
Source: Pixabay.com

Second Ever Cancer Treatment Based on Biomarkers Approved by FDA

On November 26, 2018, a new drug was given accelerated approval by the FDA. Not only that, but it was granted orphan drug designation and breakthrough therapy designation. The drug…

Continue Reading Second Ever Cancer Treatment Based on Biomarkers Approved by FDA
‘Digital Therapeutics’ Offers Interesting New Options for Treating Some Neurological Disorders
Source: Pixabay.com

‘Digital Therapeutics’ Offers Interesting New Options for Treating Some Neurological Disorders

Join us into the future for a moment as we take you through some exciting new developments in health tech! Just last week, the FDA cleared reSET, a mobile app that…

Continue Reading ‘Digital Therapeutics’ Offers Interesting New Options for Treating Some Neurological Disorders
Her Rare Condition Revealed his Rare Ability: Amy and Sam’s Service Dog Story
Source: Pixabay.com

Her Rare Condition Revealed his Rare Ability: Amy and Sam’s Service Dog Story

Amy Dahm, who currently lives in Washington, DC, was working as a U.S. diplomat when she was diagnosed with Cushing’s syndrome. After receiving life-saving treatment from the National Institutes of…

Continue Reading Her Rare Condition Revealed his Rare Ability: Amy and Sam’s Service Dog Story
Genome Sequencing Offers Promise for Children with Rare Developmental Delays and Other Genetic Rare Diseases
source: pixabay.com

Genome Sequencing Offers Promise for Children with Rare Developmental Delays and Other Genetic Rare Diseases

  For many families, when their child is born with developmental delays, there may be weeks, months, or even years that go by without a diagnosis. During this time, parents…

Continue Reading Genome Sequencing Offers Promise for Children with Rare Developmental Delays and Other Genetic Rare Diseases
Experimental Hepatorenal Syndrome Drug Gets Orphan Drug Designation
stevepb / Pixabay

Experimental Hepatorenal Syndrome Drug Gets Orphan Drug Designation

According to a story from accesswire.com, the drug developer BioVie, Inc., recently announced that the US Food and Drug Administration (FDA) has granted Orphan Drug designation to the company's investigational…

Continue Reading Experimental Hepatorenal Syndrome Drug Gets Orphan Drug Designation
Close Menu